ArticleOncoTargets and therapy2021

IFNγ/PD-L1 Signaling Improves the Responsiveness of Anti-PD-1 Therapy in Colorectal Cancer: An in vitro Study.

Wenli Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.